'Patrys and Hefei Co-source are moving towards finalising formal documents for this agreement, which should be executed during the third quarter of 2015. Patrys will receive an upfront payment at that time and retains the right to develop and commercialise PAT-SC1 outside of China.'
From thread asx announcement.
'should' get some cash by end of september.
Maybe enough to fix SM6 manufacture and turn the company around completely.
Not too sure on drug regulations in China, but if it works could get to market quite quickly or faster than other markets.
Perhaps a great punt at 1 cent
Ann: Patrys to License Chinese Rights for PAT-SC1, page-60
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.258M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 24181784 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7489761 | 10 |
View Market Depth
| Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable